6.38
Real-Time Quote
 +0.19 / +3.07%
Today’s Change
3.80
Today|||52-Week Range
11.48
+22.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.5B

Company Description

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company's product AFREZZA inhalation powder, which is an ultra rapid-acting insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Valencia, CA.

Contact Information

MannKind Corp.
28903 North Avenue Paine
Valencia California 91355
P:(661) 775-5300
Investor Relations:
(661) 295-4784

Employees

Shareholders

Individual stakeholders38.30%
Mutual fund holders11.68%
Other institutional10.32%

Top Executives

Alfred E. MannChairman & Chief Executive Officer
Hakan S. EdstromPresident, Chief Operating Officer & Director
Matthew J. PfefferCFO, Vice President & Head-Investor Relations
Juergen A. MartensChief Technology Officer & VP-Technical Operations
David B. ThomsonSecretary, Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.